Alpha 2.0
Login Register
» Authors » Callie E Bounds

Callie E Bounds

Explore the profile of Callie E Bounds including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 76
Followers 0
Related Specialties
Allergy & Immunology
General Medicine
Science
Top 10 Co-Authors
Drew Hannaman
Lesley C Dupuy
Connie S Schmaljohn
Jin-An Jiao
Hua Wu
Jay W Hooper
Steven A Kwilas
Nancy A Niemuth
Anne S De Groot
Thomas L Rudge Jr
Published In
Hum Vaccin Immunother
PLoS One
Vaccine
J Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay
Anderson M, Niemuth N, Sabourin C, Badorrek C, Bounds C, Rudge Jr T
PLoS One . 2020 Aug; 15(8):e0238196. PMID: 32841291
The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the devastating 2014-2016 outbreak of Ebola virus (EBOV) disease (EVD) in Guinea, Sierra Leone, and Liberia that...
2.
Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques
Rosenke K, Bounds C, Hanley P, Saturday G, Sullivan E, Wu H, et al.
J Infect Dis . 2018 Jul; 218(suppl_5):S658-S661. PMID: 30053153
Antibody therapy has been used to treat a variety of diseases and the success of ZMapp and other monoclonal antibody-based therapies during the 2014-2016 West African Ebola outbreak has shown...
3.
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice
Bounds C, Terry F, Moise L, Hannaman D, Martin W, De Groot A, et al.
Hum Vaccin Immunother . 2017 Jun; 13(12):2824-2836. PMID: 28575582
Immunoinformatics tools were used to predict human leukocyte antigen (HLA) class II-restricted T cell epitopes within the envelope glycoproteins and nucleocapsid proteins of Ebola virus (EBOV) and Sudan virus (SUDV)...
4.
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses
Bounds C, Kwilas S, Kuehne A, Brannan J, Bakken R, Dye J, et al.
PLoS One . 2015 Oct; 10(9):e0137786. PMID: 26422247
DNA vaccination of transchromosomal bovines (TcBs) with DNA vaccines expressing the codon-optimized (co) glycoprotein (GP) genes of Ebola virus (EBOV) and Sudan virus (SUDV) produce fully human polyclonal antibodies (pAbs)...
5.
Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges
Grant-Klein R, Altamura L, Badger C, Bounds C, Van Deusen N, Kwilas S, et al.
Hum Vaccin Immunother . 2015 May; 11(8):1991-2004. PMID: 25996997
Cynomolgus macaques were vaccinated by intramuscular electroporation with DNA plasmids expressing codon-optimized glycoprotein (GP) genes of Ebola virus (EBOV) or Marburg virus (MARV) or a combination of codon-optimized GP DNA...
6.
Vaccine generated immunity targets an HPV16 E7 HLA-A2.1-restricted CD8(+) T cell epitope relocated to an early gene or a late gene of the cottontail rabbit papillomavirus (CRPV) genome in HLA-A2.1 transgenic rabbits
Bounds C, Hu J, Cladel N, Balogh K, Christensen N
Vaccine . 2010 Dec; 29(6):1194-200. PMID: 21167863
The newly established HLA-A2.1 transgenic rabbit model has proven useful for testing the immunogenicity of well known and computer-predicted A2-restricted epitopes. In the current study we compared the protective immunity...